Rahim M. Naimi

534 total citations
18 papers, 411 citations indexed

About

Rahim M. Naimi is a scholar working on Nutrition and Dietetics, Gastroenterology and Surgery. According to data from OpenAlex, Rahim M. Naimi has authored 18 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nutrition and Dietetics, 9 papers in Gastroenterology and 6 papers in Surgery. Recurrent topics in Rahim M. Naimi's work include Clinical Nutrition and Gastroenterology (16 papers), Gastrointestinal motility and disorders (9 papers) and Gastroesophageal reflux and treatments (5 papers). Rahim M. Naimi is often cited by papers focused on Clinical Nutrition and Gastroenterology (16 papers), Gastrointestinal motility and disorders (9 papers) and Gastroesophageal reflux and treatments (5 papers). Rahim M. Naimi collaborates with scholars based in Denmark and China. Rahim M. Naimi's co-authors include Palle Bekker Jeppesen, Mark Hvistendahl, Christopher F. Brandt, Siri Tribler, Jens J. Holst, Bolette Hartmann, Michael Staun, Preben Bo Mortensen, Karine Madsen and Jan Lysgaard Madsen and has published in prestigious journals such as Gastroenterology, EBioMedicine and Journal of Parenteral and Enteral Nutrition.

In The Last Decade

Rahim M. Naimi

17 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rahim M. Naimi Denmark	10	277	156	123	112	86	18	411
Mark Hvistendahl Denmark	13	320 1.2×	164 1.1×	135 1.1×	126 1.1×	83 1.0×	27	469
John K. Siepler United States	9	177 0.6×	38 0.2×	109 0.9×	91 0.8×	16 0.2×	15	301
William N. Baskin United States	12	210 0.8×	245 1.6×	66 0.5×	101 0.9×	61 0.7×	15	468
Aravind Reddy Kuchkuntla United States	8	60 0.2×	129 0.8×	125 1.0×	22 0.2×	7 0.1×	15	300
P. Kar Australia	13	126 0.5×	68 0.4×	113 0.9×	65 0.6×	33 0.4×	25	466
Caroline E. Cousins Australia	9	97 0.4×	112 0.7×	99 0.8×	66 0.6×	44 0.5×	11	470
C.A. Wardle United Kingdom	9	246 0.9×	24 0.2×	53 0.4×	71 0.6×	5 0.1×	10	396
Alison A. O’Loughlin United States	12	279 1.0×	136 0.9×	90 0.7×	44 0.4×	3 0.0×	19	379
Christine Carney United Kingdom	7	183 0.7×	55 0.4×	31 0.3×	54 0.5×	16 0.2×	8	396
Susan M. Kirkpatrick Canada	6	105 0.4×	125 0.8×	127 1.0×	56 0.5×	9 0.1×	6	294

Countries citing papers authored by Rahim M. Naimi

Since Specialization

Citations

This map shows the geographic impact of Rahim M. Naimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahim M. Naimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahim M. Naimi more than expected).

Fields of papers citing papers by Rahim M. Naimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahim M. Naimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahim M. Naimi. The network helps show where Rahim M. Naimi may publish in the future.

Co-authorship network of co-authors of Rahim M. Naimi

This figure shows the co-authorship network connecting the top 25 collaborators of Rahim M. Naimi. A scholar is included among the top collaborators of Rahim M. Naimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahim M. Naimi. Rahim M. Naimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ankersen, Dorit Vedel, et al.. (2024). The Costs of Home Monitoring by Telemedicine vs Standard Care for Inflammatory Bowel Diseases—A Danish Register-Based, 5-Year Follow-up Study. Journal of Crohn s and Colitis. 19(2). 2 indexed citations

Naimi, Rahim M., Mark Hvistendahl, Steen Seier Poulsen, et al.. (2022). Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial. Journal of Parenteral and Enteral Nutrition. 47(1). 140–150. 14 indexed citations

Naimi, Rahim M., Mark Hvistendahl, C. Christiansen, et al.. (2021). Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study. BMJ Open Gastroenterology. 8(1). e000604–e000604. 7 indexed citations

Hvistendahl, Mark, Rahim M. Naimi, Svend Høime Hansen, et al.. (2021). Bile acid–farnesoid X receptor–fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial. Journal of Parenteral and Enteral Nutrition. 46(4). 923–935. 12 indexed citations

Hvistendahl, Mark, Rahim M. Naimi, Lotte Hahn Enevoldsen, et al.. (2020). Effect of Glepaglutide, a Long‐Acting Glucagon‐Like Peptide‐2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial. Journal of Parenteral and Enteral Nutrition. 44(8). 1535–1544. 33 indexed citations

Naimi, Rahim M., Mark Hvistendahl, Nikolaj Nerup, et al.. (2019). Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial. EBioMedicine. 46. 444–451. 24 indexed citations

Naimi, Rahim M., Mark Hvistendahl, Lotte Hahn Enevoldsen, et al.. (2019). Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. The Lancet. Gastroenterology & hepatology. 4(5). 354–363. 61 indexed citations

Sun, Haifeng, et al.. (2019). Repeated Metabolic Balance Studies in Patients With Short Bowel Syndrome. Journal of Parenteral and Enteral Nutrition. 44(4). 677–687. 6 indexed citations

Hvistendahl, Mark, Rahim M. Naimi, Lotte Hahn Enevoldsen, et al.. (2018). Su1982 - Glepaglutide, a Glucagon-Like Peptide-2 Analog, Ameliorates Accelerated Gastrointestinal Transit Time in Patients with Short Bowel Syndrome. Gastroenterology. 154(6). S–655. 1 indexed citations

10.

Hvistendahl, Mark, Rahim M. Naimi, Mark Berner Hansen, & Palle Bekker Jeppesen. (2018). 794 - Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Absorption of Macronutrients, Body Weight and Lean Body Mass in Patients with Short Bowel Syndrome. Gastroenterology. 154(6). S–1359. 1 indexed citations

11.

Naimi, Rahim M., Mark Hvistendahl, Steen Seier Poulsen, et al.. (2018). 755 - Effects of Short-Term Treatment with Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Intestinal Morphology and Citrulline in Patients with Short Bowel Syndrome. Gastroenterology. 154(6). S–160. 1 indexed citations

12.

Brandt, Christopher F., Mark Hvistendahl, Rahim M. Naimi, et al.. (2016). Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center. Journal of Parenteral and Enteral Nutrition. 41(7). 1178–1187. 70 indexed citations

13.

Brandt, Christopher F., Siri Tribler, Mark Hvistendahl, et al.. (2016). Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: Catheter‐Related Complications Over 4 Decades at the Main Danish Tertiary Referral Center. Journal of Parenteral and Enteral Nutrition. 42(1). 95–103. 47 indexed citations

14.

Hvistendahl, Mark, Christopher F. Brandt, Siri Tribler, et al.. (2016). Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open‐Label Pilot Study. Journal of Parenteral and Enteral Nutrition. 42(1). 112–121. 48 indexed citations

15.

Brandt, Christopher F., Mark Hvistendahl, Siri Tribler, et al.. (2015). Su1457 Hospital Admissions in Adult Intestinal Failure Patients Receiving Home Parenteral Nutrition: 40 Years of Experience at a Referral Intestinal Failure Center in Denmark. Gastroenterology. 148(4). S–517. 1 indexed citations

16.

Hvistendahl, Mark, Christopher F. Brandt, Siri Tribler, et al.. (2015). 965 The Glucagon-Like Peptide 1 Agonist Liraglutide Reduces Jejunostomy Output and Improves Intestinal Absorption in Short Bowel Syndrome Patients With Intestinal Failure; A Pilot Study. Gastroenterology. 148(4). S–188.

17.

Naimi, Rahim M., Karine Madsen, Christopher F. Brandt, et al.. (2013). A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients. Regulatory Peptides. 184. 47–53. 10 indexed citations

18.

Madsen, Karine, Rahim M. Naimi, Christopher F. Brandt, et al.. (2013). Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regulatory Peptides. 184. 30–39. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact